Mosaic Mutations

Some genetic abnormalities that appear to have sprung up independently in children are in fact present in a portion of their parents’ cells.

Written byKate Yandell
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, SCIENCEGENETICSWhen a couple has a child with a genetic disorder, they often ask how likely they are to pass the disorder on to another child. To determine the risk of this happening, clinicians must figure out when the disorder-associated mutation arose: Did it spring up de novo during the creation of the sperm or egg that contributed to the child’s genetic makeup, or did already-present genetic abnormalities in the parents form a causative combination?

There is also a third possibility: one parent might harbor some abnormal cells derived from mutations that arose early on during his or her own life. These mutations may not have obvious health effects and can go unnoticed in most genetic screens. Researchers have long recognized this possibility, but a paper published today (July 31) in The American Journal of Human Genetics attempts to better quantify the phenomenon of mosaicism.

The authors used extra-sensitive molecular methods to analyze the blood of 100 couples who have children with disorders caused by DNA deletions, all of which were initially determined to be de novo. But with the more rigorous blood test, members of four of the couples were found to have the same mutations as their children, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies